Bitcoin's Puell Multiple, which measures miner revenue against its yearly average, has reached its highest cycle low at 0.53, the strongest since 2018. This indicates miners are earning more relative to past cycles, reflecting shallower price drops rather than effects from halvings. Historically, Puell lows below 0.65 have preceded significant 180-day gains averaging 55%, suggesting potential upside with limited downside risk. Meanwhile, large Bitcoin holders are absorbing selling pressure from retail traders near $64,700, supporting price stability and higher lows. Continued accumulation by big players is key to maintaining this market strength, with a reclaim of $64,800 as a critical level to watch next.
Axsome Therapeutics received an "Outperform" rating from BMO Capital due to significant progress in its drug pipeline, including FDA acceptance of its NDA for AXS-12, a narcolepsy treatment with a PDUFA date set for May 1, 2027. The company is also a...
Novartis is set to report its Q2 earnings with analysts expecting an EPS of $2.17 and revenue of $14.07 billion, following a tough Q1 affected by major patent expirations. Despite revenue challenges, the company maintained strong cash flow of $3.30 b...
KeyCorp is set to report earnings with analysts forecasting a 20% increase in earnings per share to $0.42 and an 8% rise in total revenue to $1.97 billion. The growth is mainly driven by a 10% increase in net interest income, fueled by strong commerc...
Several biotech and manufacturing companies saw significant stock declines due to key corporate events. Vision Marine Technologies dropped nearly 24% after shifting its focus from boat manufacturing to a mining project, causing investor uncertainty. ...
Shares of Zhengye Biotechnology surged over 1047% to regain Nasdaq compliance after a minimum bid price warning. Advanced Biomed and Axe Compute also saw notable gains following a reverse stock split and Russell Microcap Index inclusion, respectively...
